Lantern Pharma Inc.
LTRN
$3.75
-$0.18-4.58%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.55% | -30.63% | -25.58% | -25.17% | -22.31% |
| Total Receivables | -- | -- | -- | 45.27% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.30% | -41.12% | -51.78% | -43.03% | 63.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -6.15% | -24.24% | -82.06% | -65.71% | -71.99% |
| Total Current Assets | -36.91% | -30.86% | -28.45% | -26.19% | -23.53% |
|
|
|||||
| Total Current Assets | -36.91% | -30.86% | -28.45% | -26.19% | -23.53% |
| Net Property, Plant & Equipment | 4.97% | -26.49% | -23.09% | 193.00% | 152.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.70% | 23.55% | -21.52% | 44.69% | 44.69% |
| Total Assets | -36.59% | -30.80% | -28.42% | -25.82% | -23.15% |
|
|
|||||
| Total Accounts Payable | 62.42% | 42.58% | 35.88% | 1.05% | 59.16% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.44% | 0.55% | 48.83% | 227.03% | 82.61% |
| Total Finance Division Other Current Liabilities | 65.70% | 74.55% | 45.46% | -13.79% | -74.96% |
| Total Other Current Liabilities | 65.70% | 74.55% | 45.46% | -13.79% | -74.96% |
| Total Current Liabilities | 59.81% | 52.55% | 41.54% | -4.29% | -28.22% |
|
|
|||||
| Total Current Liabilities | 59.81% | 52.55% | 41.54% | -4.29% | -28.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.74% | -63.70% | -88.90% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 56.58% | 47.01% | 35.29% | -2.09% | -24.82% |
|
|
|||||
| Common Stock & APIC | 0.17% | 0.17% | 0.44% | 0.59% | 1.31% |
| Retained Earnings | -37.39% | -37.05% | -40.64% | -40.63% | -42.22% |
| Treasury Stock & Other | 81.77% | 97.48% | 100.63% | 71.06% | 68.09% |
| Total Common Equity | -41.43% | -35.91% | -31.97% | -27.00% | -23.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.43% | -35.91% | -31.97% | -27.00% | -23.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.43% | -35.91% | -31.97% | -27.00% | -23.06% |
|
|
|||||
